uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Suicide risk and antipsychotic side effects in schizophrenia: nested case-control study.
Karolinska Inst, Karolinska Univ Hosp, Dept Med, Ctr Pharmacoepidemiol CPE, SE-17176 Stockholm, Sweden.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för neurovetenskap, Psykiatri, Akademiska sjukhuset.
Karolinska Inst, Karolinska Univ Hosp, Dept Med, Ctr Pharmacoepidemiol CPE, SE-17176 Stockholm, Sweden.; Golestan Univ Med Sci, Fac Med, Gorgan, Iran..
Karolinska Inst, Karolinska Univ Hosp, Dept Med, Ctr Pharmacoepidemiol CPE, SE-17176 Stockholm, Sweden.
Vise andre og tillknytning
2016 (engelsk)Inngår i: Human Psychopharmacology: Clinical and Experimental, ISSN 0885-6222, E-ISSN 1099-1077, Vol. 31, nr 4, s. 341-345Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

OBJECTIVE: This study explores suicide risk in schizophrenia in relation to side effects from antipsychotic medication.

METHODS: Among patients with a first clinical discharge diagnosis of schizophrenia or schizoaffective disorder in Stockholm County between 1984 and 2000 (n = 4000), those who died by suicide within 5 years from diagnosis were defined as cases (n = 84; 54% male). For each case, one individually matched control was identified from the same population. Information on antipsychotic side effects, including extrapyramidal symptoms (EPS) and akathisia, as well as prescriptions of anticholinergic medication, was retrieved from clinical records in a blinded fashion. Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) of the association between suicide and side effects as well as anticholinergic medication were estimated using conditional logistic regression.

RESULTS: A lower suicide risk was found in patients with a history of EPS (aOR 0.33, 95% CI 0.12-0.94). There was no statistically significant association between akathisia or anticholinergic medication use and the suicide risk.

CONCLUSIONS: A lower suicide risk identified among patients with EPS could potentially reflect higher antipsychotic adherence, exposure to higher dosage, or polypharmacy among these patients.

sted, utgiver, år, opplag, sider
2016. Vol. 31, nr 4, s. 341-345
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-288908DOI: 10.1002/hup.2536ISI: 000379939200010PubMedID: 27108775OAI: oai:DiVA.org:uu-288908DiVA, id: diva2:924421
Forskningsfinansiär
Stockholm County CouncilSwedish Research Council, K2007-62X-15078-04-3, K2008-62P-20597-01-3Tilgjengelig fra: 2016-04-28 Laget: 2016-04-28 Sist oppdatert: 2017-11-30bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Clapham, EricBodén, Robert

Søk i DiVA

Av forfatter/redaktør
Clapham, EricBodén, Robert
Av organisasjonen
I samme tidsskrift
Human Psychopharmacology: Clinical and Experimental

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 470 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf